JLJingping Li

Jingping Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jingping Li has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Weikang Chen

    Department of Reproductive Endocrinology, the Women's Hospital, Zhejiang University School of Medicine

    4 shared publications
  • Feidi Li

    School of Public Health and Management, Wenzhou Medical University, Wenzhou 325035, China

    2 shared publications
  • Feng-Bin Zhang

    Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China

    2 shared publications
  • Gang Chen

    Hospital Infection Control Management Department, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China

    2 shared publications
  • Guangyuan Liu

    School of Public Health and Management, Wenzhou Medical University, Wenzhou 325035, China

    2 shared publications
  • Hong Huang

    School of Public Health, Wenzhou Medical University, China

    2 shared publications

Latest Publications

  • Open Access

    A homozygous SPDYA variant associated with meiotic arrest and failed microdissection testicular sperm extraction in non-obstructive azoospermia

    by Huimei Zheng, Yunbo Wang, Jia Wang, Weikang Chen, Jianhua Chen, Xiaohang Yang, Fan Jin, Yongmei Xi, Jingping Li

    Background: Non-obstructive azoospermia (NOA) with meiotic maturation arrest is a severe form of male infertility for which genetic diagnosis may inform counseling and sperm-retrieval expectations. Methods: Whole-exome sequencing was performed in a consanguineous family with NOA, followed by SPDYA variant screening in 31 unrelated NOA patients and 469 men with documented reproductive outcomes. The proband underwent clinical evaluation and microdissection testicular sperm extraction (micro-TESE). Testicular histology, immunofluorescence staining, and meiotic chromosome-spread analysis were used to assess spermatogenic progression. Structural modeling, immunoblotting, co-immunoprecipitation, and exploratory bulk RNA sequencing were performed using testicular material from the proband and a pooled obstructive azoospermia control reference. The three libraries per condition were technical library replicates, not independent biological replicates. Results: A homozygous SPDYA missense variant (NM_182756.4:c.596G>A; p.R199H) was identified in the proband, and both parents were heterozygous carriers. No additional biallelic deleterious SPDYA variants were detected in the screening cohort. The patient showed NOA, reduced testicular volume, spermatocyte-stage maturation arrest, and failed micro-TESE. Cytological analyses showed absence of post-meiotic germ cells, persistent nuclear γH2AX, failed XY body formation, and no pachytene or diplotene spermatocytes. Structural modeling and co-immunoprecipitation were compatible with weakened SPDYA-CDK2 association, and immunoblotting showed lower apparent abundance of SPDYA, CDK2, and SUN1 in the patient sample. Exploratory transcriptomic profiling showed fold-change-based tissue-level trends consistent with early meiotic arrest and loss of post-meiotic germ-cell programs, rather than direct transcriptional effects of the variant. Conclusion: This single case suggests that biallelic SPDYA variants may be associated with poor sperm retrieval outcomes in severe meiotic arrest, but larger multicenter cohorts are strictly required before SPDYA can be used for clinical prediction or surgical decision-making.

  • Open Access

    Greater seminal vesicle volume is associated with higher sperm DNA fragmentation and lower motility, but not with sperm output: a cross-sectional study of 1,482 men

    by Jingping Li, Chong Chen, Huimei Zheng, Weikang Chen, Shai Li, Lin Chai, Yikan Feng, Maolin Su

    Background: Sperm DNA fragmentation is associated with adverse reproductive outcomes, but its cause is often unclear. Infection and inflammation may promote post-testicular oxidative damage, and seminal vesicle involvement can alter the antioxidant-rich seminal plasma and produce gland enlargement or abnormal echotexture on transrectal ultrasonography. We examined whether seminal vesicle volume and echotexture were associated with the sperm DNA fragmentation index (DFI) and conventional semen parameters. Methods: We included 1,482 men from one reproductive medicine centre in Hangzhou, China, whose ultrasound was performed on or within 90 days before their first DFI test. Bilateral total volume (1 SD = 2.73 mL) was primary; echotexture was secondary and DFI ≥ 30% the primary outcome. Models adjusted for age, varicocele and both abstinence intervals. In an uncontrolled cohort of men with seminal vesicle enlargement or abnormal echotexture, DFI was compared before and after antibiotic monotherapy in 24 retested men. Results: DFI was ≥ 30% in 319 of the 1,482 men (21.5%). Each 1 SD greater bilateral total volume was associated with DFI ≥ 30% (adjusted odds ratio 1.83, 95% CI 1.60–2.10), and the association departed from linearity (P = 0.006). The same increment corresponded to a DFI 16.4% higher (12.9–20.1) and progressive motility 17.0% lower (13.2–20.7), with sperm concentration −3.2% (−7.9 to 1.7) and total sperm number 1.9% (−3.3 to 7.3). Heterogeneous or flocculent echotexture was likewise associated with DFI ≥ 30% (adjusted odds ratio 4.23 per category, 2.79–6.41), although this association weakened after adjustment for volume. Adding volume to the clinical model raised the area under the curve from 0.657 to 0.729 (optimism-corrected 0.718). In these 24 men the median within-man change in DFI was −13.5 percentage points. Conclusions: Greater seminal vesicle volume was associated with a higher DFI and lower sperm motility, but not with sperm output. An enlarged seminal vesicle therefore identifies men worth testing for DNA fragmentation. Whether antibiotics lower DFI in men with an abnormal seminal vesicle needs evaluation in a controlled trial. Trial registration: Not applicable.

  • Corrigendum to “Association between residential greenness exposure and semen quality: A retrospective study in China” [Environ. Int. 193 (2024) 109132]

    by Xuchao Dai, Weikang Chen, Guangyuan Liu, Feidi Li, Shuren Sun, Qi Chen, Gang Chen, Mengqi Zhang, Zhenfeng Wang, Wenyuan Li, et al.

  • Optimizing Y-chromosome microdeletion screening in Chinese male infertility patients: a large-scale multi-centre study on incidence

    by Wei-Kang Chen, Zu-Bo Liu, Tong-Tong Lin, Yuan-Yuan Zhou, Le-Jun Li, Zhong-Yan Liang, Jing-Gen Wu, Fu Luo, Ke-Da Yu, Feng-Bin Zhang, et al.

    STUDY QUESTION: What is the optimal sperm concentration threshold for screening Y-chromosome microdeletions (YCMs) in male infertility patients? SUMMARY ANSWER: This study identified three clinically relevant screening thresholds: an receiver operating characteristic (ROC)-optimal cutoff at 0.45 million sperm/ml, a high-sensitivity cutoff at 8 million sperm/ml, and a cost-effective threshold at 1 million sperm/ml. WHAT IS KNOWN ALREADY: YCMs are the second most common genetic cause of male infertility, however, current screening thresholds remain controversial due to limited supporting evidence. STUDY DESIGN, SIZE, DURATION: This retrospective multi-centre cohort study included 6806 male patients who underwent fertility assessments and azoospermia factor (AZF) gene testing between September 2013 and January 2024. PARTICIPANTS/MATERIALS, SETTING, METHODS: ROC analysis was used to determine the AUC to show the effectiveness of sperm concentration for predicting AZF deletions. The sensitivity and specificity of different sperm concentration screening thresholds were measured. MAIN RESULTS AND THE ROLE OF CHANCE: The incidence of YCMs was found to be 12.71% in non-obstructive azoospermia patients, 13.35% in patients with sperm concentrations between 0 and 1 million/ml, and 3.56% in those between 1 and 5 million/ml. ROC analysis demonstrated that sperm concentration was a good predictor of AZF deletions (AUC: 0.75, 95% CI: 0.74–0.77). The optimal threshold of 0.45 million/ml yielded a sensitivity of 86.84%, specificity of 59.97%, positive predictive value (PPV) of 13.48%, and negative predictive value (NPV) of 98.45%. A threshold of 8 million/ml achieved maximum sensitivity of 100.00% and NPV of 100.00%, but with specificity of 30.32% and PPV of 9.34%. The model showed good calibration with a Brier score of 0.06 and a goodness-of-fit test P-value of 0.726. Cost-effectiveness analysis revealed that a threshold of 1 million/ml provided the lowest incremental cost-effectiveness ratio. LIMITATIONS, REASONS FOR CAUTION: Firstly, despite being the largest cohort study to date, our data primarily originated from eastern China, particularly the Zhejiang region. A nationwide multi-centre study could further validate our findings across different Chinese populations. Secondly, our cost-effectiveness analysis uses general gross domestics product-based willingness-to-pay thresholds, while disease-specific thresholds might be more appropriate and could be explored through nationwide surveys. Moreover, it is important to note that our cost-effectiveness findings are specifically based on the Chinese healthcare system and may not be directly applicable to other countries due to variations in healthcare systems, insurance coverage, and patient payment responsibilities across different regions globally. Another limitation of our cost-effectiveness analysis is that it may not fully capture the complex downstream implications of YCM detection in non-azoospermic men, where the primary impact relates to reproductive choices. Future studies should consider incorporating intergenerational effects and the potential costs of ART in subsequent generations when evaluating the true cost-effectiveness of YCM screening strategies. Thirdly, while we rigorously excluded cases with obstructive factors, the retrospective nature of our study might have introduced an inherent selection bias that could be addressed in future prospective studies. Fourthly, due to challenges in data collection, precise information on abstinence duration for some patients was unavailable and, therefore, not included in this article. We plan to further explore their potential impact on our conclusions in future prospective studies. WIDER IMPLICATIONS OF THE FINDINGS: This large-scale study provides comprehensive evidence for optimizing YCM screening strategies in male infertility evaluations. STUDY FUNDING/COMPETING INTEREST(S): This project was supported by the Medical and Health Technology Program of Zhejiang Province (2025KY085), the Zhejiang Health Information Association Research Program (2024XHSZ-Z05), the Scientific Research Fund of Zhejiang Provincial Education Department (Y202249537), and the National Natural Science Foundation of China (82471638). There are no known competing interests. TRIAL REGISTRATION NUMBER: N/A.


  • Open Access

    Association between residential greenness exposure and semen quality: A retrospective study in China

    by Xuchao Dai, Weikang Chen, Guangyuan Liu, Feidi Li, Shuren Sun, Qi Chen, Gang Chen, Mengqi Zhang, Zhenfeng Wang, Wenyuan Li, et al.


  • Re-assessment of the close relationship between serum FSH levels and semen quality: a retrospective cohort study of 11,929 Chinese men

    by Wei-Kang Chen, Jing-Ping Li, Feng-Bin Zhang, Zhong-Yan Liang, Le-Jun Li, Jing-Gen Wu

    Purpose To establish a medically valuable normal reference interval of follicle-stimulating hormone (FSH) levels in males with normal semen and to assess the predictive value of FSH in males exhibiting semen abnormalities. Methods The study involved male patients who underwent their initial serum sex hormone test and semen test between October 2013 and June 2023. The reference interval was identified as the 95% confidence interval (CI) of FSH values in the patients with normal semen parameters. Then, in the total study population, receiver operating characteristic (ROC) curves were performed to evaluate the discriminatory ability of FSH for oligozoospermia and non-obstructive azoospermia (NOA). Besides, multivariable logistic regression was performed to investigate the association of FSH with oligozoospermia and NOA adjusted by age. Results A total of 11,929 patients were finally enrolled in the study. The normal reference interval of FSH ranged from 1.70 IU/L to 7.60 IU/L (median: 3.98 IU/L) based on 4595 patients with normal semen routine parameters. In the total patients, ROC curves showed FSH to have a “fair” discriminatory ability for oligozoospermia (area under receiver operating characteristic curve (AUC) 0.747, threshold 7.32 IU/L, accuracy 0.734, positive predictive value (PPV) 0.754, negative predictive value (NPV) 0.726), while ROC curves showed FSH to have a “excellent” discriminatory ability for NOA (AUC: 0.921, threshold 10.18 IU/L, accuracy 0.903, PPV 0.593, NPV 0.972). Besides, multivariable logistic regression showed that FSH ≥ 7.32 IU/L was associated with a 8.51-fold increase in the risk of oligozoospermia adjusted by age, while FSH ≥ 10.18 IU/L was associated with a 38.93-fold increase in the risk of NOA. Conclusions Our findings indicated that the reference interval for FSH in males with normal semen was 1.70–7.60 IU/L and found that FSH was capable of effectively discerning oligospermia and NOA.


  • Open Access

    X-linked RBBP7 mutation causes maturation arrest and testicular tumors

    by Jingping Li, Huimei Zheng, Jiaru Hou, Jianhua Chen, Fengbin Zhang, Xiaohang Yang, Fan Jin, Yongmei Xi

    Maturation arrest (MA) is a subtype of non-obstructive azoospermia, and male infertility is a known risk factor for testicular tumors. However, the genetic basis for many affected individuals remains unknown. Here, we identified a deleterious hemizygous variant of X-linked retinoblastoma-binding protein 7 (RBBP7) as a potential key cause of MA, which was also found to be associated with the development of Leydig cell tumors. This mutation resulted in premature protein translation termination, affecting the sixth WD40 domain of the RBBP7 and the interaction of the mutated RBBP7 with histone H4. Decreased BRCA1 and increased γH2AX were observed in the proband. In mouse spermatogonial and pachytene spermatocyte-derived cells, deprivation of rbbp7 led to cell cycle arrest and apoptosis. In Drosophila, knockdown of RBBP7/Caf1-55 in germ cells resulted in complete absence of germ cells and reduced testis size, whereas knockdown of RBBP7/Caf1-55 in cyst cells resulted in hyperproliferative testicular cells. Interestingly, male infertility caused by Caf1-55 deficiency was rescued by ectopic expression of wild-type human RBBP7 but not mutant variants, suggesting the importance of RBBP7 in spermatogenesis. Our study provides insights into the mechanisms underlying the co-occurrence of MA and testicular tumors and may pave the way for innovative genetic diagnostics of these 2 diseases.